Front Endocrinol (Lausanne) 14(12):735824 Hidayat K, Du X, Shi BM (2019) Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies
Glucagon-like peptide-1 (GLP-1) receptor agonist and dual agonist therapies are FDA-approved for the treatment of obesity, weight management, type 2 diabetes mellitus and cardiovascular mortality reduction
Notably, a study by Finan et al
Nutrition, strength training and overall lifestyle habits still play a huge role in egg quality, sperm health and pregnancy outcomes
No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man
Why Muscle Mass Is Important Muscle mass helps us burn calories by boosting our metabolism